Date
Attendees
Committee Member | Present | Absent |
---|
| X |
|
| X |
|
Warren Kibbe |
| X |
|
|
|
Gregory Tawa |
| X |
William Hendriks |
| X |
Matthew Breen |
| X |
Roel Verhaak |
|
|
Goals
- Review, discuss, and prioritize ICDC study submission proposals
Outstanding Action items
- Matthew & Warren to write an email request to Toby pertaining to formalization of a business plan for ICDC.
- Musk, Philip (NIH/NCI) [C] to brush up on Nanostring documentation.
Agenda
Discussion Item | Who | Notes |
---|
New data submission request | | |
Data submission recommended by DGAB to the Senior Advisory Committee | | - "Immune Pathways and TP53 missense mutations are associated with longer survival in canine osteosarcoma"
- Data Submission Folder: OSA-Normal
|
PRECINCT Data Request Submission: Inhaled IL-15 Immunotherapy for Treatment of Lung Metastases | | - PRECINCT SharePoint submission folder
- PRECINCT Publication
- Recently met with UC Davis team to demo the ICDC and discuss next steps for ingesting additional data.
|
Review of other Modiano publications: Other Modiano Publication Considerations.xlsx | | |
Study Updates | | - TCL01
- Study identifier changed to TCL01 (Tumor Cell Line)
- Testing completed
- Pending release record available on production
- 6 study files being assembled
- PRECINCT
- Program now available on lower tier (dev environment)
- Study record is in place
- PANCAN01 (15 TB Re-analysis)
- Data is already in a ICDC S3 bucket
- Template-driven study onboarding initiated
- One study will be onboarded at a time
|
Minutes (Not Verbatim)
The meeting was cancelled and an email was sent instead to initiate a review of the newest data submission request.
Action items